Clinical Trial Update: Intensity Modulated Radiation Therapy for Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating intensity-modulated radiation therapy for nasopharyngeal neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Neoplasms

Snippet

Sponsor: University Health Network, Toronto | Conditions: Nasopharyngeal Neoplasms | Phase 2 | Status: COMPLETED